Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People's Republic of China.
Key Laboratory of Early Prevention and Treatment for Regional High-Incidence-Tumor, Guangxi Medical University, Ministry of Education, Nanning, Guangxi, People's Republic of China.
Eur Radiol. 2023 Mar;33(3):2171-2184. doi: 10.1007/s00330-022-09201-8. Epub 2022 Nov 10.
To establish an effective dynamic nomogram combining magnetic resonance imaging (MRI) findings of primary tumor and regional lymph nodes with tumor stage for the pretreatment prediction of induction chemotherapy (IC) response in locoregionally advanced nasopharyngeal carcinoma (LANPC).
A total of 498 LANPC patients (372 in the training and 126 in the validation cohort) with MRI information were enrolled. All patients were classified as "favorable responders" and "unfavorable responders" according to tumor response to IC. A nomogram for IC response was built based on the results of the logistic regression model. Also, the Cox regression analysis was used to identify the independent prognostic factors of disease-free survival (DFS).
After two cycles of IC, 340 patients were classified as "favorable responders" and 158 patients as "unfavorable responders." Calibration curves revealed satisfactory agreement between the predicted and the observed probabilities. The nomogram achieved an AUC of 0.855 (95% CI, 0.781-0.930) for predicting IC response, which outperformed TNM staging (AUC, 0.661; 95% CI 0.565-0.758) and the MRI feature-based model alone (AUC, 0.744; 95% CI 0.650-0.839) in the validation cohort. The nomogram was used to categorize patients into high- and low-response groups. An online dynamic model was built ( https://nomogram-for-icresponse-prediction.shinyapps.io/DynNomapp/ ) to facilitate the application of the nomogram. In the Cox multivariate analysis, clinical stage, tumor necrosis, EBV DNA levels, and cervical lymph node numbers were independently associated with DFS.
The comprehensive nomogram incorporating MRI features and tumor stage could assist physicians in predicting IC response and formulating personalized treatment strategies for LANPC patients.
• The nomogram can predict IC response in endemic LANPC. • The nomogram combining tumor stage with MRI-based tumor features showed very good predictive performance. • The nomogram was transformed into a web-based dynamic model to optimize clinical application.
建立一个有效的动态列线图,将原发肿瘤和区域淋巴结的磁共振成像(MRI)表现与肿瘤分期相结合,用于预测局部晚期鼻咽癌(LANPC)患者新辅助化疗(IC)的反应。
共纳入 498 例具有 MRI 信息的 LANPC 患者(训练队列 372 例,验证队列 126 例)。所有患者根据 IC 治疗后肿瘤的反应分为“有利反应者”和“不利反应者”。基于逻辑回归模型的结果,建立了 IC 反应的列线图。此外,采用 Cox 回归分析确定无病生存(DFS)的独立预后因素。
经过 2 个周期的 IC 治疗,340 例患者被归类为“有利反应者”,158 例患者被归类为“不利反应者”。校准曲线显示预测概率与观察概率之间具有良好的一致性。该列线图在预测 IC 反应方面的 AUC 为 0.855(95%CI,0.781-0.930),优于 TNM 分期(AUC,0.661;95%CI,0.565-0.758)和单独基于 MRI 特征的模型(AUC,0.744;95%CI,0.650-0.839)在验证队列中。该列线图用于将患者分为高反应和低反应组。建立了一个在线动态模型(https://nomogram-for-icresponse-prediction.shinyapps.io/DynNomapp/),以方便列线图的应用。在 Cox 多因素分析中,临床分期、肿瘤坏死、EBV DNA 水平和颈部淋巴结数量与 DFS 独立相关。
综合纳入 MRI 特征和肿瘤分期的列线图可以帮助医生预测 IC 反应,并为 LANPC 患者制定个体化治疗策略。